{"id":4567,"date":"2016-10-05T08:30:48","date_gmt":"2016-10-05T12:30:48","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4567"},"modified":"2016-10-05T08:30:48","modified_gmt":"2016-10-05T12:30:48","slug":"novel-study-of-pancreatic-cancer-aims-to-give-patients-more-treatment-options","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4567","title":{"rendered":"Novel study of pancreatic cancer aims to give patients more treatment options"},"content":{"rendered":"<p>(By Sharon Begley for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">J<\/span>ust <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK50895\/\" target=\"_blank\">3 percent<\/a><sup class=\"footnote\">1<\/sup> of adult cancer patients participate in clinical trials of experimental treatments. In a novel effort to boost that number, a national nonprofit is launching an unusual study \u2014 one that allows patients to move easily between several experimental therapies, without spending precious time trying to find and qualify for a new trial if the first one doesn\u2019t help. <a href=\"https:\/\/www.statnews.com\/2016\/10\/04\/pancreatic-cancer-clincial-trial\/\" target=\"_blank\">Continue reading article here&#8230;..<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"stat-logo\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Sharon Begley for STAT) Just 3 percent1 of adult cancer patients participate in clinical trials of experimental treatments. In<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-4567","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4567"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4567\/revisions"}],"predecessor-version":[{"id":4568,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4567\/revisions\/4568"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}